Patent: 4,897,389
✉ Email this page to a colleague
Summary for Patent: 4,897,389
Title: | Treating central nervous system diseases |
Abstract: | A method of treating human suffering from central nervous system diseases, such as Alzheimer\'s disease, Parkinson\'s disease, senile dementia. The treatment consists of inducing into the patient\'s blood stream at least one from the group consisting of: sex hormones and anabolic hormones. Growth hormone is also being used in those patients in advanced stages of the disease, or in those patients where it has been determined that a low level of growth hormone is present. A method of diagnosing Alzheimer\'s disease, senile dementia, by the determination of the levels of the hormones somatotropin (human growth hormone) and somatomedin-C (IGF-I) after the administration of the Aroonsakul-Allen provocative test is also disclosed. Blood-sera samples are taken at certain time periods after the administration of L-Dopa, and the samples are tested for the levels of these hormones. These levels are then compared against the levels for normal subjects. |
Inventor(s): | Aroonsakul; Chaovanee (Chicago, IL) |
Assignee: | |
Application Number: | 07/293,134 |
Patent Claims: | see list of patent claims |
Details for Patent 4,897,389
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2007-01-30 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2007-01-30 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2007-01-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |